CIK: 1450485 - Address: Connaught House, 1 Burlington Road, Dublin, 4 Ireland
27 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11388-11-1262
P%wins10067333303344

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/13/24 17:40
2/9/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOExec VicM.d00.0003822210M
1/25/24 18:24
1/23/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOExec VicS.dm-87424.980-35-16188D
1/9/24 21:17
1/6/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOExec VicM.d00.0007579170D
12/6/23 17:18
12/4/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOExec VicS-41520.760-20-10171D
2/13/23 16:56
2/9/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOCEOM.d00.0003825191D
3/2/22 18:21
2/28/22
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.000129150D
2/23/22 16:13
2/21/22
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.0001411138D
11/17/21 17:03
11/15/21
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOS-20120.150-10-9104D
6/15/21 17:04
6/14/21
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.00054114D
3/2/21 19:21
2/28/21
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.0001213109D
2/23/21 21:01
2/21/21
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.000141797D
7/2/20 18:13
6/30/20
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.00012519784D
6/30/20 19:40
6/27/20
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.000406660D
6/16/20 17:03
6/14/20
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.000458620D
3/11/20 08:40
3/10/20
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOP1041.0609821575D
2/25/20 16:50
2/21/20
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.00013740477D
6/28/19 17:03
6/27/19
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.0004014325D
6/17/19 17:42
6/14/19
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.0004519285D
4/1/19 08:23
3/29/19
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOP501.7602913240D
6/29/18 16:00
6/27/18
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOM.d00.0004042135D
6/14/17 16:05
6/14/17
PSDVPsivida Corp.DEElectrLabEqLaboratory Analytical InstrumLurker NancyMADOP,CEOP1001.76057New57D
12/8/14 16:18
12/5/14
AUXLAuxilium Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLurker NancyPADM.d49219.6702510D
12/8/14 16:18
12/5/14
AUXLAuxilium Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLurker NancyPADS.d-1,10334.000-32-7610D
11/12/14 09:25
11/7/14
PDIIPdi IncBizSvBizSvBusiness ServicesLurker NancyNJDOCEOP.dm861.7504951,018I-72-63-62-52-261-2259-3-8-3-24-25
11/7/14 07:14
11/5/14
PDIIPdi IncBizSvBizSvBusiness ServicesLurker NancyNJDOCEOP.dm991.7405731,902I-77-71-69-63-39-21-12-191425912-10-5
3/17/11 13:44
3/15/11
PDIIPdi IncBizSvBizSvBusiness ServicesLurker NancyNJOCEOM.d958.240112583D15043-10-25-11-6-3-8-230-23-13-19
8/18/09 17:16
8/17/09
PDIIPdi IncBizSvBizSvBusiness ServicesLurker NancyNJOCEOP.dm515.120104290D-50-34-12452030003-3-7-247

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact